Technology | April 23, 2013

Nucletron Debuts Flexitron Brachytherapy Afterloading Platform

New features hope to optimize the treatment delivery process

April 23, 2013 — Nucletron, an Elekta company, has introduced its redesigned Flexitron remote afterloading platform. Flexitron emphasizes safety and efficiency in the brachytherapy workflow, increasing the clinician's confidence that execution of all workflow steps will proceed as planned for brachytherapy/treatment delivery.

Key to the new Flexitron are advances to optimize the treatment delivery process. One of these features is an intuitive layout that efficiently leads the user through the treatment delivery workflow. Flexitron also includes transfer tubes that all are of the same 1000 mm length to reduce ambiguity, a "reference zero" at the entrance of the catheter, a dwell position number that directly reflects the dwell position distance and forward stepping source positioning.

Flexitron features scalable configurations with 10, 20 or 40 channels and is compatible with Nucletron applicators, Oncentra Brachy and the HDR Real-Time Prostate Solution.

For more information: www.nucletron.com

Related Content

Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Hypofractionated Radiation Provides Same Prostate Cancer Outcomes as Conventional Radiation
News | Intensity Modulated Radiation Therapy (IMRT) | October 31, 2018
An analysis led by researchers at Philadelphia’s Fox Chase Cancer Center found treating localized prostate cancer with...
Prostate Brachytherapy Shows Low Incidence of Short-Term Complications
News | Brachytherapy Systems | October 31, 2018
A new analysis of nearly 600 men receiving brachytherapy for prostate cancer shows overall procedure-related...
Prostate Radiotherapy Outcomes Better for African-Americans Than Caucasian Patients according to a study presented at ASTRO 2018. #ASTRO #ASTRO18 #ASTRO2018
Feature | Prostate Cancer | October 30, 2018
October 30, 2018 — While popular beliefs and population data suggest that African-American men are at higher risk of
News | Brachytherapy Systems, Women's Healthcare | October 25, 2018
iCAD Inc. announced new clinical research demonstrating positive outcomes supporting the use of the Xoft Axxent...
Combined Therapy Including Pelvic Lymph Node Radiation Provides Significant Benefit for Prostate Cancer Patients - late breaking study presented at ASTRO 2018.
News | Prostate Cancer | October 22, 2018
The first report of a large, international clinical trial shows that, for men who show signs of...
Boston Scientific Closes Acquisition of Augmenix Inc.
News | Prostate Cancer | October 17, 2018
Boston Scientific Corp. announced the close of its acquisition of Augmenix Inc., developer of the SpaceOAR Hydrogel...
New Guideline for Prostate Cancer Supports Shortened Radiation Therapy
News | Prostate Cancer | October 12, 2018
Three prominent medical societies issued a new clinical guideline for physicians treating men with early-stage prostate...
Xoft Electronic Brachytherapy System Effective Long-Term for Early-Stage Breast Cancer
News | Brachytherapy Systems, Women's Healthcare | October 02, 2018
Breast cancer recurrence rates for patients treated with the Xoft Axxent Electronic Brachytherapy (eBx) System that...